JP2016523250A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016523250A5 JP2016523250A5 JP2016521489A JP2016521489A JP2016523250A5 JP 2016523250 A5 JP2016523250 A5 JP 2016523250A5 JP 2016521489 A JP2016521489 A JP 2016521489A JP 2016521489 A JP2016521489 A JP 2016521489A JP 2016523250 A5 JP2016523250 A5 JP 2016523250A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- pharmaceutical dosage
- beads
- cysteamine
- motomeko
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000011324 bead Substances 0.000 claims description 98
- 239000002552 dosage form Substances 0.000 claims description 94
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 claims description 52
- 229960003151 mercaptamine Drugs 0.000 claims description 52
- 239000007771 core particle Substances 0.000 claims description 32
- 238000009826 distribution Methods 0.000 claims description 29
- 239000002245 particle Substances 0.000 claims description 22
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 21
- 150000003839 salts Chemical class 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 19
- 239000012528 membrane Substances 0.000 claims description 13
- 239000002775 capsule Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 8
- 238000004007 reversed phase HPLC Methods 0.000 claims description 8
- 238000003860 storage Methods 0.000 claims description 8
- 238000000825 ultraviolet detection Methods 0.000 claims description 8
- FEWJPZIEWOKRBE-JCYAYHJZSA-M L-tartrate(1-) Chemical compound OC(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-M 0.000 claims description 6
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 6
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 claims description 6
- 229940099500 cystamine Drugs 0.000 claims description 6
- 239000007902 hard capsule Substances 0.000 claims description 6
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 6
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 6
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 6
- NSKJTUFFDRENDM-ZVGUSBNCSA-N 2-aminoethanethiol;(2r,3r)-2,3-dihydroxybutanedioic acid Chemical compound NCCS.OC(=O)[C@H](O)[C@@H](O)C(O)=O NSKJTUFFDRENDM-ZVGUSBNCSA-N 0.000 claims description 4
- 239000011230 binding agent Substances 0.000 claims description 4
- 229940008046 cysteamine bitartrate Drugs 0.000 claims description 4
- 238000001125 extrusion Methods 0.000 claims description 4
- 239000000945 filler Substances 0.000 claims description 4
- 238000005469 granulation Methods 0.000 claims description 4
- 230000003179 granulation Effects 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 238000005563 spheronization Methods 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- 229920003138 Eudragit® L 30 D-55 Polymers 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 239000002702 enteric coating Substances 0.000 claims description 2
- 238000009505 enteric coating Methods 0.000 claims description 2
- GDCRSXZBSIRSFR-UHFFFAOYSA-N ethyl prop-2-enoate;2-methylprop-2-enoic acid Chemical compound CC(=C)C(O)=O.CCOC(=O)C=C GDCRSXZBSIRSFR-UHFFFAOYSA-N 0.000 claims description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 2
- 229960003943 hypromellose Drugs 0.000 claims description 2
- 239000012535 impurity Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 150000003892 tartrate salts Chemical class 0.000 claims description 2
- 230000001747 exhibiting effect Effects 0.000 claims 2
- 230000009089 cytolysis Effects 0.000 claims 1
- 238000000227 grinding Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 239000012458 free base Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361835965P | 2013-06-17 | 2013-06-17 | |
| US61/835,965 | 2013-06-17 | ||
| PCT/US2014/042607 WO2014204881A1 (en) | 2013-06-17 | 2014-06-17 | Delayed release cysteamine bead formulation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016523250A JP2016523250A (ja) | 2016-08-08 |
| JP2016523250A5 true JP2016523250A5 (cg-RX-API-DMAC7.html) | 2017-08-03 |
| JP6468661B2 JP6468661B2 (ja) | 2019-02-13 |
Family
ID=52019418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016521489A Active JP6468661B2 (ja) | 2013-06-17 | 2014-06-17 | 遅延放出システアミンビーズ処方、ならびにその作製方法および使用方法 |
Country Status (25)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI649100B (zh) | 2013-06-17 | 2019-02-01 | 地平線罕見醫學製藥有限責任公司 | 延遲釋放型半胱胺珠粒調配物，以及其製備及使用方法 |
| TWI659209B (zh) * | 2013-06-17 | 2019-05-11 | 地平線罕見醫學製藥有限責任公司 | 分析半胱胺組合物的方法 |
| WO2017087532A1 (en) * | 2015-11-16 | 2017-05-26 | The Regents Of The University Of California | Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine compounds |
| US10143665B2 (en) | 2015-11-17 | 2018-12-04 | Horizon Orphan Llc | Methods for storing cysteamine formulations and related methods of treatment |
| ITUA20161799A1 (it) * | 2016-03-18 | 2017-09-18 | Recordati Ind Chimica E Farmaceutica S P A | Composizione farmaceutica a rilascio prolungato comprendente cisteamina o un suo sale |
| EP3308773A1 (en) * | 2016-10-11 | 2018-04-18 | Recordati Industria Chimica E Farmaceutica SPA | Formulations of cysteamine and cysteamine derivatives |
| WO2018093364A1 (en) * | 2016-11-16 | 2018-05-24 | The Regents Of The University Of California | Formulations of cysteamine and cystamine |
| US10251850B2 (en) | 2017-01-11 | 2019-04-09 | Lupin Limited | Process for preparation of cysteamine bitartrate |
| CN110769814B (zh) * | 2017-03-15 | 2022-10-18 | 睿升公司 | 具有高载药量的中链甘油三酯的药物组合物及其相关方法 |
| EP4545069A1 (en) * | 2022-06-24 | 2025-04-30 | Sunsho Pharmaceutical Co., Ltd. | Pharmaceutical composition and method for producing same |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2809918A (en) | 1955-10-17 | 1957-10-15 | Victor M Hermelin | Sustained release pharmaceutical preparations |
| DE2010416B2 (de) | 1970-03-05 | 1979-03-29 | Hoechst Ag, 6000 Frankfurt | Oral anwendbare Arzneiform mit Retardwirkung |
| US4110441A (en) | 1974-04-29 | 1978-08-29 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. | Gamma-l-glutamyl cholamine phosphate |
| FR2471186A1 (fr) | 1979-12-10 | 1981-06-19 | Roussel Uclaf | Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation |
| US4728512A (en) | 1985-05-06 | 1988-03-01 | American Home Products Corporation | Formulations providing three distinct releases |
| US4794001A (en) | 1986-03-04 | 1988-12-27 | American Home Products Corporation | Formulations providing three distinct releases |
| US4959306A (en) | 1986-11-28 | 1990-09-25 | Sclavo, Inc. | Labeling design for a binding assay reagent |
| US5668117A (en) | 1991-02-22 | 1997-09-16 | Shapiro; Howard K. | Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments |
| US5225202A (en) | 1991-09-30 | 1993-07-06 | E. R. Squibb & Sons, Inc. | Enteric coated pharmaceutical compositions |
| US5639743A (en) | 1992-11-13 | 1997-06-17 | University Of Georgia Research Foundation | Compositions and methods for treating exocrine gland atrophy |
| CA2236344A1 (en) | 1998-04-30 | 1999-10-30 | Hemosol Inc. | Hemoglobin-haptoglobin complexes |
| UA69413C2 (uk) * | 1998-05-22 | 2004-09-15 | Брістол-Майерс Сквібб Компані | Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції |
| US6794414B1 (en) | 1998-06-17 | 2004-09-21 | Yeda Research And Development Co. Ltd. | Method and compositions for treating diseases mediated by transglutaminase activity |
| UA73092C2 (uk) | 1998-07-17 | 2005-06-15 | Брістол-Майерс Сквібб Компані | Таблетка з ентеросолюбільним покриттям і спосіб її приготування |
| CN1144585C (zh) * | 2000-12-13 | 2004-04-07 | 华扩达动物科学[I.P.2]有限公司 | 含有半胱胺或其盐类的促进动物快速生长的组合物及用途 |
| US20050004075A1 (en) | 2000-12-13 | 2005-01-06 | Walcom Animal Science (I.P.2) Limited | Composition for regulating animal growth, method of manufacture and use thereof |
| GB2377874B (en) | 2001-07-23 | 2005-06-22 | Walcom Bio Chemicals Ind Ltd | Poultry feed and the use thereof |
| US7449451B2 (en) | 2001-08-29 | 2008-11-11 | Premier Micronutrient Corporation | Use of multiple antioxidant micronutrients as systemic biological radioprotective agents against potential ionizing radiation risks |
| GB2379854B (en) | 2001-09-19 | 2006-04-19 | Walcom Animal Science | Dairy cow feed and the use thereof |
| KR100949318B1 (ko) | 2001-11-29 | 2010-03-23 | 사운드 파마슈티칼스 인코퍼레이티드 | 화학요법의 바람직하지 않은 작용을 개선하기 위한 방법과조성물 |
| DK1471902T3 (da) | 2002-01-04 | 2014-09-08 | Sound Pharmaceuticals Inc | Sammensætninger til brug i fremgangsmåder til behandling af høretab |
| GB2386817B (en) | 2002-02-20 | 2006-08-23 | Walcom Animal Science | Feed for fish and use therof |
| US8017651B2 (en) | 2002-11-22 | 2011-09-13 | Bionexus, Ltd. | Compositions and methods for the treatment of HIV-associated fat maldistribution and hyperlipidemia |
| GB2398497A (en) | 2003-02-19 | 2004-08-25 | Walcom Animal Science | Composition for improving immunity of animals |
| US8029822B2 (en) | 2003-05-22 | 2011-10-04 | Osmotica Kereskedelmi és Seolgáltató KFT | Rupturing controlled release device having a preformed passageway |
| TWI372066B (en) | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
| WO2005049002A1 (en) | 2003-11-19 | 2005-06-02 | Omega Bio-Pharma International Ltd. | Materials and methods for improving alcohol metabolism and alleviating the effects of hangovers |
| EP1696897B1 (en) | 2003-12-19 | 2011-07-06 | Omega Bio-Pharma (I.P.3) Limited | Compositions for treating diabetes |
| WO2005092914A1 (en) | 2004-03-22 | 2005-10-06 | Blue Mountain Technology Development Lab | Process for promoting proper folding of human serum albumin using a human serum albumin ligand |
| BRPI0510613A (pt) | 2004-05-03 | 2007-10-30 | Omega Bio Pharma Ip3 Ltd | cisteaminas para tratar complicações de hipercolesterolemia e diabete |
| JP2008534531A (ja) * | 2005-03-29 | 2008-08-28 | エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング | 調節物質の送達に影響を及ぼすマトリックスを有するペレットを有する多粒子の医薬剤形 |
| BRPI0607531A2 (pt) | 2005-04-20 | 2009-09-15 | Hutchinson Fred Cancer Res | métodos, composições e artigos de fabricação para intensificação da capacidade de sobrevivência de células, tecidos, órgãos e organismos |
| AR057623A1 (es) | 2005-11-28 | 2007-12-05 | Omega Bio Pharma H K Ltd | Materiales y metodos para el tratamiento de las infecciones virales |
| US20070172514A1 (en) | 2006-01-20 | 2007-07-26 | Francis Chi | Materials and methods for improving livestock productivity |
| DK1919458T6 (en) | 2006-01-27 | 2017-03-27 | Univ California | Acid-resistant coated cysteamine, cystamine and derivatives thereof |
| EP2636404B1 (en) | 2007-11-30 | 2019-03-20 | The Regents of The University of California | Methods of Treating Non-Alcoholic Steatohepatitis (Nash) Using Cysteamine Products |
| CN102006785A (zh) | 2008-02-17 | 2011-04-06 | 华扩达动物科学(I.P.3)有限公司 | 改善虾健康的材料和方法 |
| EP2405898A2 (en) | 2009-03-09 | 2012-01-18 | Council Of Scientific & Industrial Research | Sustained release composition of therapeutic agent |
| KR101571198B1 (ko) * | 2009-03-18 | 2015-11-23 | 에보니크 룀 게엠베하 | 중성 비닐 중합체 및 부형제를 포함하는 코팅을 이용하는, 에탄올의 영향에 대한 내성을 갖는 제어 방출 제약 조성물 |
| CN101653426A (zh) | 2009-09-16 | 2010-02-24 | 冯利萍 | 一种高稳型半胱胺盐酸盐的缓释小丸及制备方法 |
| CN101703472B (zh) * | 2009-11-09 | 2011-06-22 | 上海邦成生物科技有限公司 | 一种半胱胺盐酸盐制粒包衣缓释产品及其制备方法 |
| CN102077905B (zh) | 2010-12-10 | 2013-01-02 | 无锡正大畜禽有限公司 | 一种肠溶盐酸半胱胺包膜颗粒的生产方法 |
| WO2012170676A1 (en) * | 2011-06-08 | 2012-12-13 | Sti Pharma, Llc | Controlled absorption water-soluble pharmaceutically active organic compound formulation for once-daily administration |
| MY165953A (en) * | 2011-11-22 | 2018-05-18 | Univ California | Methods and compositions for treating inflammation and ischemic injury |
| TWI649100B (zh) | 2013-06-17 | 2019-02-01 | 地平線罕見醫學製藥有限責任公司 | 延遲釋放型半胱胺珠粒調配物，以及其製備及使用方法 |
-
2014
- 2014-06-16 TW TW103120757A patent/TWI649100B/zh active
- 2014-06-16 AR ARP140102285A patent/AR096628A1/es not_active Application Discontinuation
- 2014-06-17 NZ NZ714517A patent/NZ714517A/en unknown
- 2014-06-17 MX MX2015017366A patent/MX375377B/es active IP Right Grant
- 2014-06-17 EA EA201690036A patent/EA031255B8/ru unknown
- 2014-06-17 WO PCT/US2014/042607 patent/WO2014204881A1/en not_active Ceased
- 2014-06-17 EP EP21175359.5A patent/EP3939574A1/en active Pending
- 2014-06-17 CN CN201480034647.4A patent/CN105492000B/zh active Active
- 2014-06-17 TN TN2015000549A patent/TN2015000549A1/en unknown
- 2014-06-17 KR KR1020217022957A patent/KR102466253B1/ko active Active
- 2014-06-17 KR KR1020167000255A patent/KR102281747B1/ko active Active
- 2014-06-17 CN CN201910990909.9A patent/CN110664780B/zh active Active
- 2014-06-17 SG SG11201510126QA patent/SG11201510126QA/en unknown
- 2014-06-17 CA CA2938644A patent/CA2938644C/en active Active
- 2014-06-17 BR BR112015031417-1A patent/BR112015031417B1/pt active IP Right Grant
- 2014-06-17 AU AU2014281702A patent/AU2014281702C1/en active Active
- 2014-06-17 CA CA2914770A patent/CA2914770C/en active Active
- 2014-06-17 US US14/306,303 patent/US9233077B2/en active Active
- 2014-06-17 EP EP14813132.9A patent/EP3010491A4/en active Pending
- 2014-06-17 UA UAA201600331A patent/UA117833C2/uk unknown
- 2014-06-17 PH PH1/2020/552266A patent/PH12020552266A1/en unknown
- 2014-06-17 JP JP2016521489A patent/JP6468661B2/ja active Active
- 2014-06-17 AP AP2015008925A patent/AP2015008925A0/xx unknown
- 2014-06-17 IL IL302141A patent/IL302141A/en unknown
- 2014-06-17 HK HK16105019.8A patent/HK1218066A1/zh unknown
-
2015
- 2015-06-26 US US14/751,639 patent/US9173851B1/en active Active
- 2015-12-01 ZA ZA2015/08783A patent/ZA201508783B/en unknown
- 2015-12-11 US US14/966,490 patent/US20160095827A1/en not_active Abandoned
- 2015-12-14 PH PH12015502783A patent/PH12015502783A1/en unknown
- 2015-12-16 CU CUP2015000178A patent/CU20150178A7/es unknown
- 2015-12-16 NI NI201500177A patent/NI201500177A/es unknown
- 2015-12-17 CL CL2015003662A patent/CL2015003662A1/es unknown
-
2016
- 2016-02-12 US US15/042,823 patent/US20160158170A1/en not_active Abandoned
- 2016-07-26 US US15/220,308 patent/US20160331704A1/en not_active Abandoned
-
2017
- 2017-07-21 US US15/656,570 patent/US20170319513A1/en not_active Abandoned
- 2017-07-21 US US15/656,579 patent/US20170319514A1/en not_active Abandoned
- 2017-07-21 US US15/656,531 patent/US20170319512A1/en not_active Abandoned
-
2018
- 2018-12-12 US US16/218,136 patent/US11090279B2/en active Active
-
2021
- 2021-07-13 IL IL284823A patent/IL284823A/en unknown
-
2023
- 2023-03-16 AR ARP230100660A patent/AR128816A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016523250A5 (cg-RX-API-DMAC7.html) | ||
| ES2486245T3 (es) | Sobre de mesalazina con alta carga de fármaco | |
| JP5220746B2 (ja) | 制御放出システム及びその製造方法 | |
| ES2823000T3 (es) | Formulaciones muco-adhesivas de liberación controlada de levodopa y/o ésteres de levodopa y usos de las mismas | |
| JP6356215B2 (ja) | エベロリムスを含む医薬組成物 | |
| CN101977593B (zh) | 包含弱碱性药物以及有机酸的给药系统 | |
| CN119868330A (zh) | 在进食状态下具有改善的药代动力学的γ-羟基丁酸酯组合物 | |
| EA031255B1 (ru) | Состав с отсроченным высвобождением, содержащий гранулы цистеамина, и способы его получения и применения | |
| ES2623176T3 (es) | Composición farmacéutica de memantina | |
| EP3154523A1 (en) | Formulation for oral administration containing mesalazine | |
| JP2014515356A5 (cg-RX-API-DMAC7.html) | ||
| CA2905011C (en) | Extended-release topiramate capsules | |
| CA2539982A1 (en) | Pantoprazole multiparticulate formulations | |
| CN103181914A (zh) | 盐酸美金刚缓释胶囊及其制备方法 | |
| WO2012001705A2 (en) | Pharmaceutical compositions of (r)-lansoprazole | |
| CN103068372B (zh) | 代谢型谷氨酸受体5(mglu5)拮抗剂的药物组合物 | |
| CN105012301A (zh) | 代谢型谷氨酸受体5(mglu5)拮抗剂的药物组合物 | |
| JP6510093B2 (ja) | ビロキサジンの緩和放出製剤 | |
| US10172878B2 (en) | Extended-release topiramate capsules | |
| JP2016516031A5 (cg-RX-API-DMAC7.html) | ||
| CN103520136B (zh) | 孟鲁斯特钠脉冲胶囊及其制备方法 | |
| WO2011138797A2 (en) | Delayed release oral disintegrating pharmaceutical compositions of lansoprazole | |
| WO2008079102A1 (en) | Modified release loxoprofen compositions | |
| CN105326813A (zh) | 帕罗西汀缓释组合物及其制备方法 | |
| HK40013178A (en) | Delayed release cysteamine bead formulation, and methods of making and using same |